Received Feb 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPAB | HEP A + HEP B (TWINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | H7RF2 | IM / RA |
Reported Symptoms: Narrative: Patient received his first dose of Twinrix on 2/9/24, his second dose on 3/13/24, and his third dose on 6/5/24. The typical dosing schedule for Twinrix is dose #2 1 month after dose #1, and dose #2 6 months after dose #1. Patient should have received his 3rd dose in August 2024. Patient experienced no adverse events. Other Relevant HX:: Patient received his first dose of Twinrix on 2/9/24, his second dose on 3/13/24, and his third dose on 6/5/24. The typical dosing schedule for Twinrix is dose #2 1 month after dose #1, and dose #2 6 months after #1. Patient should have received his 3rd dose in August 2024. Patient experienced no adverse events. Other: N/A